Skip to Main Content

Author Details

James W Denham
University of Newcastle
1980
249
47
PMIDPaper TitleJournal TitlePublished Year
36934896Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients.Radiother Oncol2023
34955242Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.Pathology2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34462519A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.Commun Biol2021
33795769Tumor innervation and clinical outcome in pancreatic cancer.Sci Rep2021
33752126Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study.EBioMedicine2021
32285460Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial.Histopathology2020
31937919Tumour innervation and neurosignalling in prostate cancer.Nat Rev Urol2020
31843189Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.Pathology2020
32092343Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.Int J Radiat Oncol Biol Phys2020
32745667Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials.Radiother Oncol2020
32770600Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI.J Appl Clin Med Phys2020
32596153External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost.Front Oncol2020
32793485Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials.Front Oncol2020
32673785Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population.Int J Radiat Oncol Biol Phys2020
32526166The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion.Am J Pathol2020
30609205Multi-observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest.J Med Imaging Radiat Oncol2019
31555587A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow.Front Oncol2019
30579763Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.Lancet Oncol2019
30599846Characterization of prostate cancer using diffusion tensor imaging: A new perspective.Eur J Radiol2019
28872752Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.BJU Int2018
29750398Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy.BJU Int2018
29036016Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases.Med Sci Sports Exerc2018
29222833Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial.J Med Imaging Radiat Oncol2018
29122360Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial.Radiother Oncol2018
27240216Measuring personal and functional changes in prostate cancer survivors: development and validation of the FADE: data from the TROG 03.04 RADAR trial.Psychooncology2017
28185419Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based addition.J Med Imaging Radiat Oncol2017
28445167Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications.Phys Med Biol2017
28318448Psychological resilience aspects that mediate the depressive effects of urinary incontinence in prostate cancer survivors 10 years after treatment with radiation and hormone ablation.J Psychosoc Oncol2017
29594231Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications.Clin Transl Radiat Oncol2017
29280465Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.Int J Radiat Oncol Biol Phys2017
29198437Spinal Cord Injuries and Nerve Dependence in Prostate Cancer.Trends Cancer2017
29187477Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure.Anticancer Res2017
28004451Total depression and subtypes in prostate cancer survivors 10 years after treatment.Eur J Cancer Care (Engl)2017
28068247Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder Surface.Int J Radiat Oncol Biol Phys2017
27370204Independent external validation of predictive models for urinary dysfunction following external beam radiotherapy of the prostate: Issues in model development and reporting.Radiother Oncol2016
27906418Assessment of celecoxib poly(lactic-co-glycolic) acid nanoformulation on drug pharmacodynamics and pharmacokinetics in rats.Eur Rev Med Pharmacol Sci2016
27981527Examination of the pharmacodynamics and pharmacokinetics of a diclofenac poly(lactic-co-glycolic) acid nanoparticle formulation in the rat.Eur Rev Med Pharmacol Sci2016
27844331Multi-atlas and unsupervised learning approach to perirectal space segmentation in CT images.Australas Phys Eng Sci Med2016
27720692Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population.Phys Med2016
27799048Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.Radiat Oncol2016
27566370Tissue engineering and regenerative medicine in musculoskeletal oncology.Cancer Metastasis Rev2016
27147316Statistical-learning strategies generate only modestly performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: A comparison of conventional and machine-learning methods.Med Phys2016
27528117Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial.Radiother Oncol2016
25082363Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?J Med Imaging Radiat Oncol2015
26325671Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.Pathology2015
26476560Urinary symptoms following external beam radiotherapy of the prostate: Dose-symptom correlates with multiple-event and event-count models.Radiother Oncol2015
  • 1 - 50 of 249

Recommended Authors

Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 2
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 12
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 4
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 4
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 20
Stephanie Peeters
University of Liege, Centre Hospitalier Universitaire de Liege
Career Start Year 2005
Number of shared co-authors 0
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 10
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 5
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 30
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 28
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 27
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 4
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 15
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 26
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 9
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 19
Alexandra L Hanlon
Virginia Tech
Career Start Year 1994
Number of shared co-authors 6
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 6
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 3
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 34
William L Barrett
Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
Career Start Year 1992
Number of shared co-authors 2
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Career Start Year 1991
Number of shared co-authors 1
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 13
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 43
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 17
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Career Start Year 1983
Number of shared co-authors 4
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 8
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 9
Alan Pollack
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 28

Collaborators

David Joseph
Sir Charles Gairdner Hospital
Co-authored papers 85
Allison Steigler
University of Newcastle
Co-authored papers 47
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Ming-Hui Chen
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 4
Anthony V D'Amico
Duke University Medical Center
Co-authored papers 4
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 4
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 4
Lars Egevad
Karolinska Institute
Co-authored papers 4
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 4
John R Srigley
University of Toronto
Co-authored papers 4
Ting Martin Ma
University of Washington
Co-authored papers 4
Michael L Steinberg
University of California los angeles
Co-authored papers 4
Amar U Kishan
University of California los angeles
Co-authored papers 4
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Michael Xiang
University of California los angeles
Co-authored papers 3
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 3
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 3
Araceli Guerrero
Hospital Son Espases
Co-authored papers 3
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 3
Almudena Zapatero
University Hospital La Princesa
Co-authored papers 3
Thomas M Pisansky
Mayo Clinic
Co-authored papers 3
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Co-authored papers 3
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 2
Robert T Dess
University of Michigan ann arbor
Co-authored papers 2
Judith A Clements
Co-authored papers 1
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 1
Release 1.2